Stargardt Disease To Be Treated With Embryonic Stem Cells in Trial Initiated by Advanced Cell Technology
Earlier this week, Advanced Cell Technology’s request to begin treating patients with Stargardt disease (also known as fundus flavimaculatus) with embryonic stem cells in a clinical trial was approved by the FDA. This will be the second trial using human embryonic stem cells. The first being granted to Geron to treat spinal cord disease.